Cite
A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
MLA
Zhu, Zheng, et al. “A Nuclear Transport-Related Gene Signature Combined with IDH Mutation and 1p/19q Codeletion Better Predicts the Prognosis of Glioma Patients.” BMC Cancer, vol. 20, no. 1, Nov. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s12885-020-07552-3.
APA
Zhu, Z., Lan, Y., Wang, L., Ge, J., Wang, J., Liu, F., He, Z., Zhang, H., Luo, M., Lin, D., Tan, Y., Xu, Y., & Luo, T. (2020). A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients. BMC Cancer, 20(1), N.PAG. https://doi.org/10.1186/s12885-020-07552-3
Chicago
Zhu, Zheng, Yang Lan, Lihong Wang, Jia Ge, Jiao Wang, Feng Liu, Zhicheng He, et al. 2020. “A Nuclear Transport-Related Gene Signature Combined with IDH Mutation and 1p/19q Codeletion Better Predicts the Prognosis of Glioma Patients.” BMC Cancer 20 (1): N.PAG. doi:10.1186/s12885-020-07552-3.